Glow Protocol
Also known as: Glow Stack, Glow Blend, Skin Rejuvenation Stack
Key Facts: Glow Protocol
- Category
- Peptide Blend
- FDA Status
- Not FDA Approved
- Clinical Status
- Preclinical Research (Components)
- Administration
- Subcutaneous injection
- Typical Dose
- Standard vial dosing per protocol
- Frequency
- Once daily
- Evidence Level
- Animal Studies
- Duration
- 8-12 weeks for visible results
What to Expect
A multi-peptide skin rejuvenation blend combining BPC-157 (5mg), TB-500 (10mg), and GHK-Cu (27mg). Designed for anti-aging, skin health, and tissue repair with a focus on collagen production and cellular regeneration.
Mechanism of Action
GHK-Cu stimulates collagen and elastin synthesis while reducing matrix metalloproteinases. BPC-157 promotes tissue healing and angiogenesis. TB-500 enhances cell migration and new blood vessel formation. The 5:1:1 ratio (GHK-Cu:TB-500:BPC-157) optimizes skin rejuvenation benefits.
Research Summary
GHK-Cu has extensive research showing skin tightening, wrinkle reduction, and wound healing benefits. Combined with the tissue repair properties of BPC-157 and TB-500, this stack targets both surface-level skin improvements and deeper cellular regeneration.
Dosing Information
Note: Animal study doses may not translate directly to humans.
Typical Dosingⓘ
Community experience
Standard vial dosing per protocol
Varies by vendor formulation
Once daily
Skin rejuvenation stack. GHK-Cu for collagen, BPC-157 and TB-500 for tissue repair. Evening use recommended.
Research Dosingⓘ
Scientific studies
Skin-focused peptide blend
Doses from Studies
5:1:1 ratio GHK-Cu:TB-500:BPC-157
Clinical Protocols - Standard Glow formulation
Duration
8-12 weeks for visible results
Administration
Subcutaneous injection
Timing & Administration
Best Time to Take
Evening
Once daily
Food Recommendation
With or without food
Why This Timing?
Aligns with nighttime skin repair cycles. GHK-Cu works during sleep when collagen synthesis peaks.
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Injection site reactions
- ●Temporary skin flushing
- ●Mild headache (rare)
- ●Fatigue during initial use
References
Related Peptides
Peptides commonly compared with Glow Protocol or used in similar applications.
Wolverine Stack
PreclinicalThe most popular healing peptide combination, combining BPC-157 (10mg) and TB-500 (10mg). Named after the Marvel character's regenerative abilities. Used for accelerated injury recovery, joint support, and tissue repair.
Peptide BlendKLOW Blend
PreclinicalAn advanced multi-peptide blend combining BPC-157 (10mg), TB-500 (10mg), GHK-Cu (50mg), and KPV (10mg) totaling 80mg per vial. Evolution of the Glow stack with added KPV for enhanced anti-inflammatory and gut health benefits.
Peptide BlendBPC-157
PreclinicalA synthetic peptide derived from a protein found in human gastric juice. Known for its remarkable tissue healing properties across multiple body systems.
HealingTB-500
Clinical TrialsA synthetic 17-amino acid fragment of Thymosin Beta-4 (TB-4). NOT the same as TB-4 - TB-500 has a longer half-life (~2-4 days vs ~2 hours) and is the active region responsible for tissue repair and cell migration. Note: Many vendors mislabel TB-4 as 'TB-500' in premixed products.
HealingGHK-Cu
ResearchA naturally occurring copper-binding peptide found in human plasma, saliva, and urine. Widely used in skincare for its wound healing and anti-aging properties.
Skin & HairLL-37
Clinical TrialsA naturally occurring antimicrobial peptide and the only human cathelicidin. Part of the innate immune system with broad-spectrum antimicrobial activity.
ImmuneWant updates on Glow Protocol research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.
Educational Information Only
This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.